Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
We further demonstrate that oxidative mitochondrial signalling can be used as a biomarker of response to fluoropyrimidine-based chemotherapy treatment in patients with CRC and may have clinical utility for stratifying patients at higher risk who could benefit from metabolically targeted combination therapies
Patients who initiated treatment for both brands using transitional assistance continued to be subsidized by the manufacturer as they refilled their prescriptions
Read our privacy policy
Contact your insurer for details
US$ 28.22
US$ 24.53
US$ 29.32
US$ 28.92
US$ 23.45
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 23.94
US$ 25.35
